Hsu JT - Search Results

1

Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide.

Wu CJ, Jan JT, Chen CM, Hsieh HP, Hwang DR, Liu HW, Liu CY, Huang HW, Chen SC, Hong CF, Lin RK, Chao YS, Hsu JT. Wu CJ, et al. Among authors: hsu jt. Antimicrob Agents Chemother. 2004 Jul;48(7):2693-6. doi: 10.1128/AAC.48.7.2693-2696.2004. Antimicrob Agents Chemother. 2004. PMID: 15215127 Free PMC article.

2

Inhibition of hepatitis C virus replication by arsenic trioxide.

Hwang DR, Tsai YC, Lee JC, Huang KK, Lin RK, Ho CH, Chiou JM, Lin YT, Hsu JT, Yeh CT. Hwang DR, et al. Among authors: hsu jt. Antimicrob Agents Chemother. 2004 Aug;48(8):2876-82. doi: 10.1128/AAC.48.8.2876-2882.2004. Antimicrob Agents Chemother. 2004. PMID: 15273095 Free PMC article.

3

Inhibition of hepatitis C virus replication by antimonial compounds.

Hwang DR, Lin RK, Leu GZ, Lin TY, Lien TW, Yu MC, Yeh CT, Hsu JT. Hwang DR, et al. Among authors: hsu jt. Antimicrob Agents Chemother. 2005 Oct;49(10):4197-202. doi: 10.1128/AAC.49.10.4197-4202.2005. Antimicrob Agents Chemother. 2005. PMID: 16189098 Free PMC article.

4

Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV.

Hsu JT, Kuo CJ, Hsieh HP, Wang YC, Huang KK, Lin CP, Huang PF, Chen X, Liang PH. Hsu JT, et al. FEBS Lett. 2004 Sep 10;574(1-3):116-20. doi: 10.1016/j.febslet.2004.08.015. FEBS Lett. 2004. PMID: 15358550 Free PMC article.

5

Antiviral drug discovery against SARS-CoV.

Wu YS, Lin WH, Hsu JT, Hsieh HP. Wu YS, et al. Among authors: hsu jt. Curr Med Chem. 2006;13(17):2003-20. doi: 10.2174/092986706777584988. Curr Med Chem. 2006. PMID: 16842194

6

Strategies of development of antiviral agents directed against influenza virus replication.

Hsieh HP, Hsu JT. Hsieh HP, et al. Among authors: hsu jt. Curr Pharm Des. 2007;13(34):3531-42. doi: 10.2174/138161207782794248. Curr Pharm Des. 2007. PMID: 18220789 Review.

7

Anti-HSV activity of digitoxin and its possible mechanisms.

Su CT, Hsu JT, Hsieh HP, Lin PH, Chen TC, Kao CL, Lee CN, Chang SY. Su CT, et al. Among authors: hsu jt. Antiviral Res. 2008 Jul;79(1):62-70. doi: 10.1016/j.antiviral.2008.01.156. Epub 2008 Feb 21. Antiviral Res. 2008. PMID: 18353452

8

BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses.

Shih SR, Horng JT, Poon LL, Chen TC, Yeh JY, Hsieh HP, Tseng SN, Chiang C, Li WL, Chao YS, Hsu JT. Shih SR, et al. Among authors: hsu jt. J Antimicrob Chemother. 2010 Jan;65(1):63-71. doi: 10.1093/jac/dkp393. J Antimicrob Chemother. 2010. PMID: 19892833

9

Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.

Shih SR, Chu TY, Reddy GR, Tseng SN, Chen HL, Tang WF, Wu MS, Yeh JY, Chao YS, Hsu JT, Hsieh HP, Horng JT. Shih SR, et al. Among authors: hsu jt. J Biomed Sci. 2010 Feb 23;17(1):13. doi: 10.1186/1423-0127-17-13. J Biomed Sci. 2010. PMID: 20178582 Free PMC article.

10

Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.

Hsu JT, Yeh JY, Lin TJ, Li ML, Wu MS, Hsieh CF, Chou YC, Tang WF, Lau KS, Hung HC, Fang MY, Ko S, Hsieh HP, Horng JT. Hsu JT, et al. Antimicrob Agents Chemother. 2012 Feb;56(2):647-57. doi: 10.1128/AAC.00125-11. Epub 2011 Sep 19. Antimicrob Agents Chemother. 2012. PMID: 21930871 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

555 results

Search Page